跳至主要内容
临床试验/NCT05265260
NCT05265260已完成不适用

Barriers to Early Progress in Cochlear Implant Outcomes: a Non-interventional Feasibility Study

Cochlear1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2022年4月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Cochlear
入组人数
32
试验地点
1
主要终点
Score of the French MBAA2 Sentence Recognition Test in Quiet

研究概览

简要总结

The aim of this study is to understand how audiometric, cognitive and electrophysiological results relate to sentence recognition score in adults using currently a Nucleus cochlear implant.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult subjects, 18 years or older
  • Subjects unilaterally implanted or bilaterally implanted with at least 6 months separating the two cochlear implantations.
  • Subjects who have been implanted between January 2016 and December
  • Subjects have received a Nucleus CI: CI512, CI522 or CI532 cochlear implants with non-rotating magnet, or CI600 series equivalent CI612, CI622 and CI632 with rotating magnet and external sound processors CP900 or CP1000 behind-the-ear, or Kanso or Kanso 2 off-the-ear types.
  • Subjects who are fluent in French (language used in the questionnaire and speech tests)
  • Subjects who are not opposed to participating in the study
  • Subjects for who the medical record data is available throughout the defined data search period.

排除标准

  • Subjects with single-sided deafness (SSD).
  • Subjects who are not affiliated to the French Social Security.
  • Subjects who are under legal protection.

结局指标

主要结局

Score of the French MBAA2 Sentence Recognition Test in Quiet

时间窗: 1 month post activation

Participants are classified in good or poor performer based on the score of the French MBAA2 sentence recognition test. A good performer has a score of ≥90/100 correct sentence. A bad performer has a score of \<90/100 correct sentence.

次要结局

未报告次要终点

研究者

发起方
Cochlear
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验